At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top San Francisco based CFO’ operating in the Medical space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
CFO of Lemonaid Health
Follow Joe Selsavage:
About Lemonaid Health, Metromile: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Chief Financial Officer of Vensana Capital
Steve Schwen joined Split Rock Partners at the firm’s inception as Chief Financial Officer. He currently oversees the finance, accounting, operations and human resources activities of the firm. Prior to joining Split Rock Partners, Steve was Chief Financial Officer of St. Paul Venture Capital, which he joined in 1998. Before joining St. Paul Venture Capital, he spent four years in the audit practice of KPMG LLP. He provided audit and consulting services to both public and private financial services companies including investment companies, mutual funds, investment managers and investment banks. Steve became a licensed CPA in the state of Minnesota after earning a BA degree in business administration-accounting at the University of St. Thomas. He is a member of the American Institute of Certified Public Accountants and the Minnesota Society of Certified Public Accountants.
Follow Steven Schwen:
About Split Rock Partners, St. Paul Venture Capital, Vensana Capital: Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.
CFO of Vir Biotechnology
Howard Horn is the Chief Financial Officer of VIR. Previously, he led the Financial Planning and Corporate Finance functions at Biogen. Prior to joining Biogen, he held positions of increasing responsibility and was focused on the life sciences as a consultant with McKinsey & Company and as an equity research analyst at UBS. Howard holds an M.B.A from the Wharton School of the University of Pennsylvania and a B.A in Economics from Princeton University.
Follow Howard Horn:
About Vir Biotechnology: Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases.
CFO of Paramit Corporation
Rick Kent is the Chief Financial Officer at Paramit Corporation.
Follow Rick Kent:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
CFO of Paramit Corporation
Tom LaRose is CFO at Paramit Corporation.
Follow Tom LaRose:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Glenn S. Boehnlein
Chief Financial Officer & Vice President of Stryker
Follow Glenn S. Boehnlein:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Susan M. Kanaya
Senior Vice President, Finance, Chief Financial Officer and Secretary of ChemoCentryx
Ms. Susan M. Kanaya has served as our Senior Vice President, Finance, and Chief Financial Officer since January 2006, and Secretary since February 2006. Prior to joining us, Ms. Kanaya served as Senior Vice President, Finance, and Chief Financial Officer at Kosan Biosciences Inc., a biotechnology company, from 1999 to 2005. Prior to this, she served in financial management positions at SUGEN, Inc., a biotechnology company, from 1994 to 1999, most recently as Vice President, Finance, and Treasurer. Ms. Kanaya also served as Controller with high technology companies and as a public accountant with KPMG. Ms. Kanaya received her B.S. in business administration from the University of California, Berkeley.
Follow Susan M. Kanaya:
About ChemoCentryx: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
CFO of AiCure
Brian Jung is the CFO of AiCure.
Follow Brian Jung:
About AiCure: AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Stephen M. Robb
Executive Vice President – Chief Financial Officer of The Clorox Company
Stephen M. “Steve” Robb was named executive vice president – chief financial officer in 2014 after three years as senior vice president – chief financial officer. In this role, he is the senior executive responsible for Clorox’s financial activities, including accounting, reporting, internal Controls, treasury, tax and investor relations. Prior to being named CFO, Robb served as vice president – Global Finance, with responsibility for the company’s day-to-day finance operations, including tax, treasury, accounting, and financial planning and analysis. Other positions with Clorox have included vice president – Financial Planning and Analysis and vice president – Finance and Accounting, Household Segment. Robb joined Clorox in 1989 and has held assignments in several business units as well as a variety of corporate staff positions. Since 2004, Robb has overseen The Clorox Company’s cost savings efforts, a key strategic commitment for the company under its 2020 Strategy. Under his stewardship, cost savings efforts have produced an average of $100 million in savings annually. A native of Sunnyvale, Calif., Robb holds a bachelor’s degree in finance with a minor in economics from San Jose State University.
Follow Stephen M. Robb:
About The Clorox Company: The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products.
Chief Financial Officer of AliveCor
Follow John Maley:
About AliveCor: AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.
Chief Financial Officer of VitalConnect
Nathan has accrued over 13 years of operational excellence in management roles spanning finance, business development, and marketing, most recently serving as Sr. Director of Finance at Natera, a public Bay Area biotech company. Earlier experience includes tenure at a top Wall Street investment bank and Big-4 accounting firm. Nathan brings expertise in accounting, due diligence, market research, fund raising and investor relations. He holds a BA from the University of Southern California and an MBA from Wharton. When his HP 12C is not within reach, you can usually find Nathan on two wheels or two skis exploring the outdoors with his family.
Follow Nathan Weems:
About VitalConnect: VitalConnect is a wearable biosensor technology for wireless hospital and remote patient monitoring.
Chief Financial Officer of Doctor Direct
Raised $1.2BB in public/private placements and negotiated over $1.3BB in transactions at Asante Technologies, PeopleWeb Communications and Vivato Networks. As CFO for Asante Technologies exceeded analyst expectations on turnaround plan while tripling analyst coverage. As CFO, led IPO process at PeopleWeb Communications, positioned company to analysts and investment bankers. Part of senior finance team that led the spin-off of PacTel Corporation, (Vodafone Airtouch) in the 4th largest IPO in US history, concurrent with a billion dollar debt offering. As VP Finance & Controller, led M&A team that managed a total of 10 mergers/acquisitions (4 public, 6 private companies) in 26 months at Avant!-Synopsys, while company grew to 42 offices in 16 countries, over 1000 employees, annual bookings in excess of $400 MM. Arranged $700MM in syndicated financing and refinanced $250MM in convertible bonds at Conner-Seagate during explosive growth, (reached $1.2BB in revenue in 13 months).
Follow Raj Matthew:
About Doctor Direct: Doctor Direct is an exciting company in the rapidly expanding Healthcare – remote patient monitoring space.
Chief Financial Officer of Protagonist Therapeutics
Tom O’Neil is the chief financial officer of [Arcadia Biosciences](https://www.crunchbase.com/organization/arcadia-biosciences#/entity), an agricultural technology company focused on developing products that benefit the environment and human health. Prior to that, he held the same position at Sorbent Therapeutics. O’Neil has also served as the vice president of finance and marketing at ChemGenex Pharmaceuticals and as a team member at HX Diagnostics. O’Neil holds a bachelor’s degree in international relations from Pomona College and master’s degree in business administration from the University of California, Los Angeles. He lives in San Francisco, California, United States.
Follow Tom O’Neil:
About Nodality, Protagonist Therapeutics: Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Chief Financial Officer of Coherus Biosciences
McDavid Stilwell is the Chief Financial Officer at Coherus BioSciences.
Follow McDavid Stilwell:
About Coherus Biosciences: Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
CFO of Augmedix
Matteo comes to Altiscale from Exigen Capital, where he was the operating partner leading finance in early and growth-stage SaaS portfolio companies. Previously, as CFO he led the turnaround and growth of Tie Rack and Rolling Luggage group, a multinational retailer based in London. His background is in consulting with Boston Consulting Group, where he delivered growth strategies for large corporations in the IT and retail markets and as an engineer in the telecommunications industry. He holds an MBA from IESE Business School in Barcelona and a master’s in electronic engineering with a specialization in computer science.
Follow Matteo Marchetta:
About Altiscale, Augmedix: Augmedix is a tech-enabled service that allows doctors to focus on what matters most: patient care.
Acting Chief Financial Officer of AEGEA Medical
John started BeckCFO in 2007 and brings over 30 years of experience in financial management, strategic planning and execution for technology firms. John has worked with early stage companies in life sciences (medical device and pharmaceutical), fabless semiconductor, software and software as a service, hardware systems, and services. John has held full-time CFO positions with both public and private companies, and, in addition to finance, has broad experience managing cross-functional areas such as IP management, legal, treasury, risk management, HR, IT and facilities. John’s background also includes managing the accounting, finance and reporting requirements of European and Asian offices. Before starting BeckCFO, John previously served as CFO for several companies including: Silicon Bandwidth, Inc., nDSP Corporation (acquired by PixelWorks), Sigma Designs, Inc., Augeo Software, Meta-Software, Inc. (acquired by Synopsys), Sellectek Incorporated, RayLAN Corporation, Optimem and Spectra Logic subsidiaries of Cipher Data Products, and Minton Company. Prior to his tenure at technology firms, John held senior audit positions at Ernst & Young and KPMG Peat Marwick certified public accounting firms. John earned a B.S. degree in Commerce with an Accounting emphasis, cum laude, from Santa Clara University. He is also a licensed C.P.A. (inactive), with the State of California.
Follow John Beck:
About AEGEA Medical, CloudPhysics: AEGEA Medical manufactures surgical and medical instruments.
Chief Financial Officer and SVP of Corporate Development of Providence Medical Technology
Greg is an experienced corporate executive and entrepreneur, as well as a capital markets and strategic advisory expert. He brings over 30 years of experience leading and advising fast-growing companies in the medical and information technology sectors to Providence. Greg has served as Chief Financial Officer of both public and private companies. Prior to joining Providence Medical Technology Greg Curhan served as a founder and past President of Merriman Curhan Ford, a leading San Francisco-based investment bank that supported venture-backed, high-growth companies in Silicon Valley, raised over $5 billion dollars for its corporate clients and advised on numerous mergers and acquisitions. Greg is a graduate of Dartmouth College where he earned a BA in Economics and graduated Summa Cum Laude.
Follow Greg Curhan:
About Providence Medical Technology: Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions.
CEO, Acting CFO of ProMed
Mr. Ronald Jabba serves as a Chief Executive Officer and Director at ProMed Inc.
Follow Ronald Jabba:
About ProMed, Zenflow: ProMed provides billing, credentialing, and contracting services in the healthcare sector.
Chief Financial Officer of Effector Therapeutics
Michael Byrnes joined eFFECTOR Therapeutics as Chief Financial Officer in 2020.
Follow Michael Byrnes:
About Effector Therapeutics: Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
President and CFO of Xicepta Sciences
Soledad M. Manaay, who holds a PhD in International Psychology with focus in Industrial and Organizational Psychology. Dr. Manaay has extensive background in business development, management, public relations, and in strategic sales and marketing. She arrived in the US via the diplomatic service serving as a media attache. After she resigned from the foreign service she went on to become a successful entrepreneur having owned and managed a high-end boutique in Hawaii and co-publisher of a community newspaper that is now the longest-running paper of its kind in Hawaii. She also served as a real estate principal broker from 2001 to 2009 while working as PR Consultant. Most recently she owned and operated Care On Call, Inc., a home care agency with over 200 employees serving affluent clients in the San Francisco bay area. She sold her company in November 2013. Soledad is also a published author having written and published two books for young adults. In her role as President and CFO of Xicepta Sciences, Dr. Manaay brings with her several decades of experience as an entrepreneur, marketing strategist, and operations manager. When required, she also assists Dr. Hayden with his research and development work. Together, Drs. Hayden and Manaay has over 50 years of professional experience applicable to their chosen industry. They collaborate as a highly-disciplined and knowledgeable team with a goal of successfully making Xicepta a strong component of the multi-billion dollar health and wellness industry.
Follow Soledad Manaay:
About Xicepta Sciences: Xicepta Sciences, Inc. manufactures and markets a new generation of wellness products derived from molecular and embryonic materials.